Resmed (RMD) Net Income towards Common Stockholders (2009 - 2026)
Resmed (RMD) reported Net Income towards Common Stockholders of $383.43 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 1.0% from $379.71 million a year earlier but down 3.8% from the prior quarter.
Powered by 
Analysis
Resmed (RMD) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Resmed posted Net Income towards Common Stockholders of $1.52 billion, up 8.8% from FY2025.
- Net Income towards Common Stockholders has increased for five consecutive fiscal years, with a five-year compound annual growth rate of 26.3% (FY2021 to FY2026).
- By fiscal year, Net Income towards Common Stockholders came in at $1.4 billion in FY2025 (+37.2%), $1.02 billion in FY2024 (+13.7%), $897.56 million in FY2023 (+15.2%) and $779.44 million in FY2022 (+64.3%).
- Five-year quarterly Net Income towards Common Stockholders spans a low of $179.01 million in fiscal Q3 2022 and a high of $398.73 million in fiscal Q3 2026.
- Year over year, Net Income towards Common Stockholders has now increased in each of the last ten quarters, with growth averaging 24.3% over the last eight quarters.
- The high point for year-over-year Net Income towards Common Stockholders in five years was fiscal Q2 2025 (growth of 65.0%); the low point was fiscal Q2 2024 (a decline of 7.2%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $398.73 million (Q3 2026), $392.59 million (Q2 2026) and $348.54 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.17 Bn | 228.32 Bn | 4.88 Bn | 1.74 Bn |
| 2 | Abbott Laboratories | 179.42 Bn | 150.51 Bn | 7.27 Bn | 928.00 Mn |
| 3 | Danaher | 161.98 Bn | 145.80 Bn | 3.61 Bn | 870.00 Mn |
| 4 | Intuitive Surgical | 156.76 Bn | 137.18 Bn | 2.08 Bn | 522.80 Mn |
| 5 | Medtronic | 122.13 Bn | 88.00 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 117.84 Bn | 103.96 Bn | 4.50 Bn | 1.28 Bn |
| 7 | Boston Scientific | 66.19 Bn | 61.20 Bn | 3.85 Bn | 907.00 Mn |
| 8 | Becton Dickinson | 54.16 Bn | 51.31 Bn | 2.32 Bn | 377.00 Mn |
| 9 | Edwards Lifesciences | 51.35 Bn | 35.47 Bn | 1.35 Bn | 241.90 Mn |
| 10 | Resmed | 36.47 Bn | 30.54 Bn | 861.22 Mn | 383.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 383.43 Mn |
| Mar 31, 2026 | 398.73 Mn |
| Dec 31, 2025 | 392.59 Mn |
| Sep 30, 2025 | 348.54 Mn |
| Jun 30, 2025 | 379.71 Mn |
| Mar 31, 2025 | 365.04 Mn |
| Dec 31, 2024 | 344.62 Mn |
| Sep 30, 2024 | 311.36 Mn |
| Jun 30, 2024 | 292.24 Mn |
| Mar 31, 2024 | 300.49 Mn |
| Dec 31, 2023 | 208.80 Mn |
| Sep 30, 2023 | 219.42 Mn |
| Jun 30, 2023 | 229.66 Mn |
| Mar 31, 2023 | 232.50 Mn |
| Dec 31, 2022 | 224.91 Mn |
| Sep 30, 2022 | 210.48 Mn |
| Jun 30, 2022 | 195.06 Mn |
| Mar 31, 2022 | 179.01 Mn |
| Dec 31, 2021 | 201.75 Mn |
| Sep 30, 2021 | 203.61 Mn |
API Access
Resmed Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();